Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI

Table 4

Clinical follow-up outcomes within the three-month after PCI.

	Rosuvastatin (n = 90)	Ezetimibe/rosuvastatin (n = 81)	value
CV death, n (%)	3 (3.3)	1 (1.2)	0.62
Nonfatal MI, n (%)	4 (4.4)	3 (3.7)	0.72
UA, n (%)	10 (11.1)	8 (9.9)	0.81
Revascularization, n (%)	7 (7.8)	5 (6.2)	0.68
Nonfatal stroke, n (%)	0	0	—

Data are summarized as n (%). CV, cardiovascular; MI, myocardial infarction; UA, unstable angina.